Compare AP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AP | LAB |
|---|---|---|
| Founded | 1929 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.5M | 271.0M |
| IPO Year | 2018 | 2008 |
| Metric | AP | LAB |
|---|---|---|
| Price | $9.21 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.6K | ★ 952.0K |
| Earning Date | 11-11-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | 0.03 | ★ 0.26 |
| Revenue | ★ $434,166,000.00 | $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | $299.33 | ★ $2.61 |
| Revenue Growth | ★ 3.79 | N/A |
| 52 Week Low | $1.75 | $0.63 |
| 52 Week High | $12.81 | $1.72 |
| Indicator | AP | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 43.19 |
| Support Level | $8.59 | $0.63 |
| Resistance Level | $9.84 | $0.77 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 57.97 | 29.52 |
Ampco-Pittsburgh Corp manufactures and sells engineered, high-performance specialty metal products and customized equipment utilized by industry throughout the world. It operates in two business segments, namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, & other metals. The Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, & Buffalo Pumps. The company generates a majority of its revenue from the Forged & Cast Engineered Products segment. It has a business presence in the United States & other countries.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.